I need help for assignment in tableau Refining an
Sprint 4: Modules 7-8 Artifact Refining your insights summary from modules 5-6 (100 points)
Scenario – You receive this email after submitting findings from an exploratory analysis:
Dear Favorite Analyst,
Thank you for sending over the first iteration for your insights summary, I’m excited about the progress you
are making. We need to continue refining the visuals and story to make sure it’s ready distribution to the
Senior Leadership team. Unfortunately, we will not have the opportunity to present the findings in a live Q&A
session so all of your insights need to be included in an artifact that can be read and easily understood without
having to be there to explain things.
Unfortunately, simply taking screenshots from Tableau won’t give us the professional, camera-ready aesthetic
we need to communicate. Many, visuals will likely need to be rebuilt so we can have more control over the
final look. We’ll want to add text annotations to further explain what the visual is communicating, but without
making people digest whole paragraphs. As you can imagine, senior leaders have more demands on their time
and attention they have hours in the day, so we’ll need to make sure they have the most important
information served up in a simple, clean, and concise way. They need to be able to consume the insights in
less than 10 minutes, so we’ll need to be deliberate about what we highlight, what we deemphasize, and how
the insights flow together.
Since we don’t have actual business context behind why this dataset was originally pulled together, we may
have to make assumptions about what’s at stake and why.
As you refine the deck, please review the assignment objectives, requirements, and submission
expectations below.
Please send the updated slide deck (PowerPoint) by the end of week (11:59 pm CT on Sunday); late
assignments will not be accepted. PDFs will not be accepted.
Thank you again for your help!
Sincerely,
Lack of Context Leonard
Refined Insights Summary Artifact Assignment Objectives:
I. Demonstrate you can minimize unnecessary cognitive load by
a. using consistent formatting (punctuation yes or no, font size, color, annotation methods,
spacing, indentation, etc.)
b. eliminating clutter (chart borders, gridlines, data markers, clean-up axis labels, labeling data
directly instead of legends & matching color, non-strategic use of contrast, etc).
c. eliminate distractions (misalignments, blurry pictures, unnecessary complexity, wordy, etc.)
II. Demonstrate that you can focus your audience’s attention by
a. Creating a visual hierarchy to follow
b. Leveraging pre-attentive attributes in your graphics (orientation, shapes, line length, line width,
size, curvature, added marks, enclosure, hue, color intensity, special position, motion, etc.)
c. Leveraging pre-attentive attributes in your text (color, size, case, outline/enclosure, bold, italics,
spatial separation, underline/added marks).
III. Demonstrate that you can communicate insights by combining visual elements with concise text and
annotation.
IV. You’ve had 6 weeks to become familiar with the dataset and have harvested insights from your
exploratory analysis, dashboards, and first insights summary. When I grade the slides from your
refined insights summary, I will review them side-by-side with your first draft slides. I should see clear
improvement in your use of pre-attentive attributes, avoidance of chart clutter, proper use of contrast,
consistent formatting, clean slide backgrounds, etc.
V. If you simply resubmit the slides from your original insights summary, you will fail this assignment
Dataset to use for practice assignment (located in Canvas):
Leverage exploratory findings from TableauCeutical or Bookshop datasets from Modules 1-4
Assignment Requirements
1. Refine the PowerPoint deck to ensure it is aesthetically pleasing and contains a title page, executive summary,
insights slides, and an appendix (10 points)
a. Title page must look different than content pages and must contain a title, your name, course section title, and term.
b. Executive summary is to be no longer than 1 page
c. Minimum of 5, but no more than 7 insight slides
d. Appendix section must be clearly labeled using a slide the looks different than your insights slides and similar to, but
not the same as your title slide.
e. Appendix section must contain 3 slides
f. Max size of 13 slides; title page (1), executive summary (1), insight slides (7), appendix cover (1), appendix slides (3).
g. Saved you deck as FirstName_LastName_M8_RefinedInsightsSummary.pptx
h. PDFs will not be accepted.
2. Executive Summary Slide (10 points)
a. Summarize the key findings from each of the 5-7 insight slides on one page in bullet point form with no visuals.
b. Leverage pre-attentive attributes in your bullet points (assignment objective II.c)
c. Provide details about the dataset, methodology, & assumptions, as footnotes (data dates, calculations, records not
used because they weren’t clean/complete, etc).
d. Executive summary is to be no more than 1 page.
3. Insight Slides (60 points)
a. Minimum of 5, but no more than 7 insights slides
b. Insight slides must contain a headline statement that communicates the most important thing the reader should take-
away from the slide (in case they’re skimming it)
c. Communicate insights in a clear, concise, and visually engaging way.
d. Use pre-attentive attributes to call attention to the insights displayed in your visuals while deemphasizing or
eliminating clutter (assignment objective II.b)
e. No visuals in the main section (insights slides section) can be copied and pasted from Tableau, rebuild the visual in
PowerPoint so pre-attentive attributes can be leveraged. Tableau screenshots are only acceptable in the Appendix.
f. Use text annotations to enhance your visual by adding context, communicating findings, connecting the dots to other
findings on other pages, etc.
g. Ensure the reader can understand the structure of your visual by labeling axes and communicating the data being
graphed. This can be in a sub header or as a chart title.
h. At least 2 slides should contain more than 1 visual from your exploratory analysis (you built several exploratory visuals
but are only allowed 7 insight slides so it’s good to practice fitting more than one visual onto a page without
overwhelming the reader).
i. Provide details about the insight, methodology, & assumptions, as footnotes (data dates, formulas, records not used
because they weren’t clean/complete, etc).
j. Insight slides should have similar theme, but not have the exact same structure from page to page. I.e. font size, color
choice, how insights are highlighted, etc. should be consistent. However, don’t always put the chart on the left and the
text on the right or the chart on top and the text below. Don’t always have just one graphic with bullet points.
4. General Aesthetics & Content Flow (20 points)
a. Ensure the deck is free of grammar, spelling, alignment, and formatting issues.
b. Ensure the deck flows naturally from topic to topic (don’t summarize one topic go on to another then come back to a
previous topic, etc).
c. Ensure the deck is free of inconsistent theming (assignment objective I.a)
Submission Requirements
Upload the following to Canvas by 11:59 pm CT on Sunday at the end of Module 8
1. PowerPoint deck as titled in Assignment Requirement 1
,
vamsi krishna reddy_Gujjula_M2Practice_EDA.twb
0 [Rx] Count true 1 "A1:T8400:no:A1:T8400:0" true 2 0 [Distribution] Count true 1 "A1:G8038:no:A1:G8038:0" true 6 Order ID 130 [Order ID] [Rx] Order ID 0 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Order Date 7 [Order Date] [Rx] Order Date 1 date Year true "DATE" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Dispensed Pharmacy Rep 130 [Dispensed Pharmacy Rep] [Rx] Dispensed Pharmacy Rep 2 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Dispensed Region 130 [Dispensed Region] [Rx] Dispensed Region 3 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Dispensed State 130 [Dispensed State] [Rx] Dispensed State 4 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Dispensed Zip Code 20 [Dispensed Zip Code] [Rx] Dispensed Zip Code 5 integer Sum true "I8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Drug Dosage Form 130 [Drug Dosage Form] [Rx] Drug Dosage Form 6 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Drug Name 130 [Drug Name] [Rx] Drug Name 7 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Drug Route 130 [Drug Route] [Rx] Drug Route 8 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Drug Supplier 130 [Drug Supplier] [Rx] Drug Supplier 9 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Market Segment 130 [Market Segment] [Rx] Market Segment 10 string Count true "WSTR" [Rx_364BD0B048CA4AAFB763B88106E71EE4] TableauCeuticalSales 5 [TableauCeuticalSales] [Rx] TableauCeuticalSales 11 real Sum 15 true "R8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Market Penetration % 20 [Market Penetration %] [Rx] Market Penetration % 12 integer Sum true "I8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Discount 5 [Discount] [Rx] Discount 13 real Sum 15 true "R8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Product Base Margin 5 [Product Base Margin] [Rx] Product Base Margin 14 real Sum 15 true "R8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Market Size 5 [Market Size] [Rx] Market Size 15 real Sum 15 true "R8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Rx Dollars 5 [Rx Dollars] [Rx] Rx Dollars 16 real Sum 15 true "R8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Rx Profit 5 [Rx Profit] [Rx] Rx Profit 17 real Sum 15 true "R8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Rx Quantity 20 [Rx Quantity] [Rx] Rx Quantity 18 integer Sum true "I8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Unit Price 5 [Unit Price] [Rx] Unit Price 19 real Sum 15 true "R8" [Rx_364BD0B048CA4AAFB763B88106E71EE4] Order ID 130 [Order ID (Distribution)] [Distribution] Order ID 20 string Count true "WSTR" [Distribution_625682C51B75419387A0BC76BB753B88] Dispensed Pharmacy Rep 130 [Dispensed Pharmacy Rep (Distribution)] [Distribution] Dispensed Pharmacy Rep 21 string Count true "WSTR" [Distribution_625682C51B75419387A0BC76BB753B88] Dispensed Region 130 [Dispensed Region (Distribution)] [Distribution] Dispensed Region 22 string Count true "WSTR" [Distribution_625682C51B75419387A0BC76BB753B88] Distribution Method 130 [Distribution Method] [Distribution] Distribution Method 23 string Count true "WSTR" [Distribution_625682C51B75419387A0BC76BB753B88] Order Priority 130 [Order Priority] [Distribution] Order Priority 24 string Count true "WSTR" [Distribution_625682C51B75419387A0BC76BB753B88] Ship Date 7 [Ship Date] [Distribution] Ship Date 25 date Year true "DATE" [Distribution_625682C51B75419387A0BC76BB753B88] Distribution Costs 5 [Distribution Costs] [Distribution] Distribution Costs 26 real Sum 15 true "R8" [Distribution_625682C51B75419387A0BC76BB753B88] -1 "Central" "West" "South" "East" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[__tableau_internal_object_id__].[cnt:Rx_364BD0B048CA4AAFB763B88106E71EE4:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[__tableau_internal_object_id__].[cnt:Distribution_625682C51B75419387A0BC76BB753B88:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[sum:TableauCeuticalSales:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[diff:sum:Rx Profit:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[sum:Rx Profit:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[sum:Market Penetration %:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[sum:Market Size:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[sum:Rx Quantity:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[sum:Discount:qk]" "[federated.0lcln2g15ea4nu10p7gcg08w8j1o].[sum:Unit Price:qk]" "Acetaminophen, Aspirin, And Codeine Phosphate" "Adderall Xr 25" "Alimta" "Amifostine" "Aminosyn-Rf 5.2%" "Anectine" "Arduan" "Avelox" "Benadryl Preservative Free" "Bleomycin Sulfate" "Busulfex" "Capozide 25/25" "Cefizox" "Chantix" "Chlorpropamide" "Clindagel" "Cobavite" "Corzide" "Darvon Compound" "Dentipatch" "Dextrose 10% And Sodium Chloride 0.33% In Plastic Container" "Dextrose 3.3% And Sodium Chloride 0.3% In Plastic Container" "Diflucan In Sodium Chloride 0.9%" "Doriden" "Dynacirc Cr" "Enduronyl" "Esmolol Hydrochloride" "Exjade" "Flaxedil" "Foradil Certihaler" "Gastromark" "Grifulvin V" "Heparin Sodium 10,000 Units In Dextrose 5% In Plastic Container" "Humegon" "Hydrocortone" "Imodium Multi-Symptom Relief" "Isoetharine Hydrochloride S/F" "Klebcil" "Lidocaine Hydrochloride 0.2% And Dextrose 5% In Plastic Container" "Lorcet-Hd" "Meclodium" "Metoprolol Succinate" "Multaq" "Neo-Cort-Dome" "Norlestrin 28 1/50" "Oraqix" "Panheprin" "Phenelzine Sulfate" "Potassium Chloride 0.22% In Dextrose 5% In Plastic Container" "Prevpac" "Propranolol Hydrochloride Intensol" "Regonol" "Rubramin Pc" "Sodium Lactate In Plastic Container" "Sulfair Forte" "Temozolomide" "Tolectin 600" "Triesence" "Vagifem" "Vinblastine Sulfate" "Ziac" "Acylanid" "Aktob" "Albalon" "Alprazolam" "Aminosyn Ii 3.5% In Dextrose 25% In Plastic Container" "Amrix" "Anthelios 40" "Atropen" "Bacitracin Zinc-Neomycin Sulfate-Polymyxin B Sulfate" "Beyaz" "Bronkosol" "Calcitonin-Salmon" "Carisoprodol Compound" "Cephalothin" "Chlordiazachel" "Citanest" "Clistin" "Concerta" "Cyclocort" "Delflex-Lm W/ Dextrose 1.5% In Plastic Container" "Dexacidin" "Dextrose 5%, Sodium Chloride 0.2% And Potassium Chloride 5Meq" "Diastat Acudial" "Disulfiram" "Duetact" "Elixophyllin" "Eryderm" "Etrafon-A" "Fentanyl-75" "Fluoxetine Hydrochloride" "Fulvicin P/G 330" "Glipizide And Metformin Hydrochloride" "Haloperidol Lactate" "Hexalen" "Hydro-D" "Ibuprohm" "Inulin And Sodium Chloride" "Kantrex" "Letrozole" "Lodosyn" "Magnesium Sulfate In Dextrose 5% In Plastic Container" "Methergine" "Mirena" "Nandrolone Phenpropionate" "Nitrofurazone" "Ocufen" "Otobiotic" "Pentetate Zinc Trisodium" "Polytrim" "Pravachol" "Proklar" "Quelicin" "Rimactane" "Serophene" "Staphcillin" "Talwin Compound" "Thioridazine Hydrochloride Intensol" "Travasol 4.25% In Dextrose 25% In Plastic Container" "Tylox" "Veriloid" "Xylocaine W/ Epinephrine" "Ablavar" "Adderall 10" "Aldactazide" "Ambodryl" "Aminosyn Ii 5% W/ Electrolytes In Dextrose 25% W/ Calcium In Plastic Container" "Ancef In Plastic Container" "Aplenzin" "Augmentin '500'" "Bancap Hc" "Bio-Tropin" "Bupivacaine Hydrochloride" "Camila" "Ceenu" "Cerumenex" "Chloromycetin Hydrocortisone" "Claritin Reditabs" "Clopra-"Yellow"" "Cor-Oticin" "Cytosar-U" "Demadex" "Dexone 0.5" "Dextrose 5%, Sodium Chloride 0.33% And Potassium Chloride 30Meq In Plastic Container" "Didanosine" "Diutensen-R" "Duranest" "Emgel" "Erythromycin Stearate" "Eutron" "Fexofenadine Hydrochloride" "Foamcoat" "Gallium Citrate Ga 67" "Glumetza"
Collepals.com Plagiarism Free Papers
Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we'll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.
Get ZERO PLAGIARISM, HUMAN WRITTEN ESSAYS
Why Hire Collepals.com writers to do your paper?
Quality- We are experienced and have access to ample research materials.
We write plagiarism Free Content
Confidential- We never share or sell your personal information to third parties.
Support-Chat with us today! We are always waiting to answer all your questions.
